$OPCH
Option Care Health, Inc.

2021 Q4 Form 10-K Financial Statement

#000101473922000009 Filed on February 23, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $927.2M $3.439B $804.7M
YoY Change 15.22% 13.39% 11.64%
Cost Of Revenue $715.0M $2.659B $621.0M
YoY Change 15.14% 13.13% 13.92%
Gross Profit $212.2M $779.6M $183.8M
YoY Change 15.47% 14.27% 4.62%
Gross Profit Margin 22.89% 22.67% 22.84%
Selling, General & Admin $136.8M $525.7M $130.8M
YoY Change 4.57% 5.1% -9.04%
% of Gross Profit 64.46% 67.43% 71.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $15.98M $63.06M $17.80M
YoY Change -10.2% -11.57% -5.82%
% of Gross Profit 7.53% 8.09% 9.69%
Operating Expenses $151.4M $588.8M $139.4M
YoY Change 8.63% 3.02% -13.63%
Operating Profit $60.77M $190.8M $44.34M
YoY Change 37.05% 72.31% 217.35%
Interest Expense -$12.82M $67.00M -$22.70M
YoY Change -43.51% -37.83% -21.18%
% of Operating Profit -21.1% 35.11% -51.19%
Other Income/Expense, Net -$10.77M -$13.37M -$23.00M
YoY Change -53.18% 15.88% 7566.67%
Pretax Income $46.97M $116.5M $18.40M
YoY Change 155.26% -2321.9% -224.32%
Income Tax -$28.50M -$23.40M $600.0K
% Of Pretax Income -60.68% -20.09% 3.26%
Net Earnings $75.47M $139.9M $17.84M
YoY Change 323.05% -1832.27% -212.83%
Net Earnings / Revenue 8.14% 4.07% 2.22%
Basic Earnings Per Share $0.78 $0.10
Diluted Earnings Per Share $415.4K $0.77 $0.10
COMMON SHARES
Basic Shares Outstanding 179.9M shares 179.9M shares 186.8M shares
Diluted Shares Outstanding 181.2M shares

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $119.4M $119.4M $99.30M
YoY Change 20.26% 20.26% 47.99%
Cash & Equivalents $119.4M $119.4M $99.27M
Short-Term Investments
Other Short-Term Assets $69.50M $69.50M $70.80M
YoY Change -1.84% -1.84% 38.01%
Inventory $183.1M $183.1M $158.6M
Prepaid Expenses
Receivables $338.2M $338.2M $328.3M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $710.3M $710.3M $657.0M
YoY Change 8.1% 8.11% 17.61%
LONG-TERM ASSETS
Property, Plant & Equipment $111.5M $186.3M $121.1M
YoY Change -7.94% -1.89% -9.05%
Goodwill $1.478B $1.429B
YoY Change 3.43% 0.22%
Intangibles
YoY Change
Long-Term Investments $20.10M $20.10M $17.00M
YoY Change 18.24% 0.0%
Other Assets $23.73M $30.67M $20.82M
YoY Change 13.99% 47.43% -8.44%
Total Long-Term Assets $2.081B $2.081B $1.990B
YoY Change 4.53% 4.53% -1.99%
TOTAL ASSETS
Total Short-Term Assets $710.3M $710.3M $657.0M
Total Long-Term Assets $2.081B $2.081B $1.990B
Total Assets $2.791B $2.791B $2.647B
YoY Change 5.42% 5.42% 2.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $279.2M $279.2M $282.9M
YoY Change -1.3% -1.29% 27.98%
Accrued Expenses $174.4M $174.4M $130.7M
YoY Change 33.47% 33.68% 31.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $6.000M $6.000M $9.250M
YoY Change -35.14% -35.48% 0.0%
Total Short-Term Liabilities $459.7M $459.7M $434.0M
YoY Change 5.91% 5.92% 31.52%
LONG-TERM LIABILITIES
Long-Term Debt $1.060B $1.060B $1.115B
YoY Change -4.95% -4.95% -12.69%
Other Long-Term Liabilities $20.95M $95.44M $8.474M
YoY Change 147.17% 20.35% -43.82%
Total Long-Term Liabilities $1.155B $1.155B $1.198B
YoY Change -3.54% -3.27% -11.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $459.7M $459.7M $434.0M
Total Long-Term Liabilities $1.155B $1.155B $1.198B
Total Liabilities $1.615B $1.615B $1.632B
YoY Change -1.02% -1.02% -3.03%
SHAREHOLDERS EQUITY
Retained Earnings $39.87M -$100.0M
YoY Change -139.85% 8.78%
Common Stock $1.139B $1.129B
YoY Change 0.85% 11.99%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.403M $2.403M
YoY Change 0.0% 0.0%
Treasury Stock Shares 383.7K shares 383.7K shares
Shareholders Equity $1.176B $1.176B $1.016B
YoY Change
Total Liabilities & Shareholders Equity $2.791B $2.791B $2.647B
YoY Change 5.42% 5.42% 2.24%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income $75.47M $139.9M $17.84M
YoY Change 323.05% -1832.27% -212.83%
Depreciation, Depletion And Amortization $15.98M $63.06M $17.80M
YoY Change -10.2% -11.57% -5.82%
Cash From Operating Activities $65.31M $208.6M $25.70M
YoY Change 154.12% 63.72% 12.23%
INVESTING ACTIVITIES
Capital Expenditures -$13.89M $25.63M -$14.00M
YoY Change -0.8% -4.63% -7.28%
Acquisitions $85.91M
YoY Change
Other Investing Activities -$67.06M $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$80.95M -$111.5M -$14.00M
YoY Change 478.18% 323.56% -7.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -65.80M -$76.87M -52.40M
YoY Change 25.57% 11.65% -906.15%
NET CHANGE
Cash From Operating Activities 65.31M $208.6M 25.70M
Cash From Investing Activities -80.95M -$111.5M -14.00M
Cash From Financing Activities -65.80M -$76.87M -52.40M
Net Change In Cash -81.43M $20.16M -40.70M
YoY Change 100.08% -37.42% -384.62%
FREE CASH FLOW
Cash From Operating Activities $65.31M $208.6M $25.70M
Capital Expenditures -$13.89M $25.63M -$14.00M
Free Cash Flow $79.20M $182.9M $39.70M
YoY Change 99.49% 82.0% 4.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
179938417 shares
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001014739
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.25
CY2020Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.25
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-11993
CY2021 dei Entity Registrant Name
EntityRegistrantName
OPTION CARE HEALTH, INC.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
05-0489664
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
3000 Lakeside Dr.
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300N
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Bannockburn
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60015
CY2021 dei City Area Code
CityAreaCode
312
CY2021 dei Local Phone Number
LocalPhoneNumber
940-2443
CY2021 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
CY2021 dei Trading Symbol
TradingSymbol
OPCH
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
2451675967 USD
CY2021 dei Auditor Name
AuditorName
KPMG LLP
CY2021 dei Auditor Location
AuditorLocation
Chicago, Illinois
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
119423000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99265000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
338242000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
328340000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
183095000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
158601000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
69496000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
70806000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
710256000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
657012000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111535000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
121149000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
74777000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
68795000 USD
CY2021Q4 bios Finite Lived Intangible Assets Net Excluding Customer Lists
FiniteLivedIntangibleAssetsNetExcludingCustomerLists
21433000 USD
CY2020Q4 bios Finite Lived Intangible Assets Net Excluding Customer Lists
FiniteLivedIntangibleAssetsNetExcludingCustomerLists
23429000 USD
CY2021Q4 bios Finite Lived Customer Lists Net
FiniteLivedCustomerListsNet
344587000 USD
CY2020Q4 bios Finite Lived Customer Lists Net
FiniteLivedCustomerListsNet
327623000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
1477564000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
1428610000 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
27033000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23733000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20821000 USD
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
2080662000 USD
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1990427000 USD
CY2021Q4 us-gaap Assets
Assets
2790918000 USD
CY2020Q4 us-gaap Assets
Assets
2647439000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
279246000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
282913000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
83503000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
58899000 USD
CY2021Q4 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
71857000 USD
CY2020Q4 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
64075000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
19089000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
18886000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6000000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
9250000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
459695000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
434023000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1059900000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1115103000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
74492000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
70776000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3339000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20945000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8474000 USD
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1155337000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1197692000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
1615032000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
1631715000 USD
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
12500000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
12500000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
180309637 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
179925915 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
180178308 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
179794586 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
18000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
18000 USD
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
383722 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
383722 shares
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2403000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2403000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1138855000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1129312000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
39867000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-100031000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-451000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11172000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1175886000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1015724000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2790918000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2647439000 USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3438640000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3032610000 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2310417000 USD
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2659034000 USD
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2350346000 USD
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1797418000 USD
CY2021 us-gaap Gross Profit
GrossProfit
779606000 USD
CY2020 us-gaap Gross Profit
GrossProfit
682264000 USD
CY2019 us-gaap Gross Profit
GrossProfit
512999000 USD
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
525707000 USD
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
500199000 USD
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
459628000 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
63058000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
71310000 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
53690000 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
588765000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
571509000 USD
CY2019 us-gaap Operating Expenses
OperatingExpenses
513318000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
190841000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
110755000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-319000 USD
CY2021 us-gaap Interest Expense
InterestExpense
67003000 USD
CY2020 us-gaap Interest Expense
InterestExpense
107770000 USD
CY2019 us-gaap Interest Expense
InterestExpense
73724000 USD
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
6030000 USD
CY2020 us-gaap Investment Income Net
InvestmentIncomeNet
3313000 USD
CY2019 us-gaap Investment Income Net
InvestmentIncomeNet
2840000 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13374000 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11541000 USD
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6991000 USD
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-74347000 USD
CY2020 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-115998000 USD
CY2019 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-77875000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
116494000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5243000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-78194000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-23404000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2833000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2274000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
139898000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-8076000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-75920000 USD
CY2021 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
0 USD
CY2020 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
0 USD
CY2019 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
-259000 USD
CY2021 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
10721000 USD
CY2020 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-3977000 USD
CY2019 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-8039000 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
10721000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3977000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8039000 USD
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
150619000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12053000 USD
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-83959000 USD
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179855000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180971000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
156280000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181205000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180971000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156280000 shares
CY2021 us-gaap Net Income Loss
NetIncomeLoss
139898000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-8076000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-75920000 USD
CY2021 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
68804000 USD
CY2020 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
77896000 USD
CY2019 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
57869000 USD
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
15168000 USD
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
18814000 USD
CY2019 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
19719000 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-30372000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1196000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4607000 USD
CY2021 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-767000 USD
CY2020 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-742000 USD
CY2019 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-3269000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-13387000 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-11545000 USD
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5469000 USD
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4998000 USD
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5517000 USD
CY2019 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4544000 USD
CY2021 bios Loss On Discontinuance Of Cash Flow Hedge Derivative
LossOnDiscontinuanceOfCashFlowHedgeDerivative
0 USD
CY2020 bios Loss On Discontinuance Of Cash Flow Hedge Derivative
LossOnDiscontinuanceOfCashFlowHedgeDerivative
3746000 USD
CY2019 bios Loss On Discontinuance Of Cash Flow Hedge Derivative
LossOnDiscontinuanceOfCashFlowHedgeDerivative
0 USD
CY2021 us-gaap Paid In Kind Interest
PaidInKindInterest
0 USD
CY2020 us-gaap Paid In Kind Interest
PaidInKindInterest
7525000 USD
CY2019 us-gaap Paid In Kind Interest
PaidInKindInterest
12256000 USD
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6030000 USD
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3313000 USD
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2840000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
9575000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2920000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
4170000 USD
CY2021 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2900000 USD
CY2020 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3250000 USD
CY2019 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
500000 USD
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2020 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-1500000 USD
CY2019 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-300000 USD
CY2021 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
844000 USD
CY2020 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0 USD
CY2019 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-688000 USD
CY2021 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
4273000 USD
CY2020 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
3924000 USD
CY2019 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-82285000 USD
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
22700000 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
42725000 USD
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12853000 USD
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1420000 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
19500000 USD
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2940000 USD
CY2021 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-10381000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
59215000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-30856000 USD
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
23977000 USD
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
13134000 USD
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2671000 USD
CY2021 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
18383000 USD
CY2020 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
22809000 USD
CY2019 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-317000 USD
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
18496000 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
18089000 USD
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
17253000 USD
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-700000 USD
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
3790000 USD
CY2019 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
4711000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
208569000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
127392000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
39467000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25632000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26875000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28292000 USD
CY2021 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2020 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2019 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
10000 USD
CY2021 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 USD
CY2020 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 USD
CY2019 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
626000 USD
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
85909000 USD
CY2020 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
700170000 USD
CY2021 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2020 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-541000 USD
CY2019 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-111541000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26334000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-727826000 USD
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
CY2020 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
CY2019 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2000000 USD
CY2021 bios Proceeds From Sale Of Management Notes Receivable
ProceedsFromSaleOfManagementNotesReceivable
0 USD
CY2020 bios Proceeds From Sale Of Management Notes Receivable
ProceedsFromSaleOfManagementNotesReceivable
0 USD
CY2019 bios Proceeds From Sale Of Management Notes Receivable
ProceedsFromSaleOfManagementNotesReceivable
1310000 USD
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
32000 USD
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
904000 USD
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2501000 USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
118934000 USD
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2021 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
855136000 USD
CY2020 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
CY2019 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
981050000 USD
CY2021 us-gaap Repayments Of Debt
RepaymentsOfDebt
8832000 USD
CY2020 us-gaap Repayments Of Debt
RepaymentsOfDebt
9250000 USD
CY2019 us-gaap Repayments Of Debt
RepaymentsOfDebt
2075000 USD
CY2021 us-gaap Payments For Deposits Applied To Debt Retirements
PaymentsForDepositsAppliedToDebtRetirements
910345000 USD
CY2020 us-gaap Payments For Deposits Applied To Debt Retirements
PaymentsForDepositsAppliedToDebtRetirements
174000000 USD
CY2019 us-gaap Payments For Deposits Applied To Debt Retirements
PaymentsForDepositsAppliedToDebtRetirements
226738000 USD
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
10339000 USD
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
149000 USD
CY2019 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
30022000 USD
CY2021 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
2458000 USD
CY2020 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
3480000 USD
CY2019 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-76870000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-68849000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
719024000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20158000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32209000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
30665000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99265000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
67056000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36391000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
119423000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99265000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
67056000 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
60920000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
97640000 USD
CY2019 us-gaap Interest Paid Net
InterestPaidNet
50808000 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5706000 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2884000 USD
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2405000 USD
CY2021 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
26174000 USD
CY2020 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
26809000 USD
CY2019 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
18992000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
602825000 USD
CY2019 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
387044000 USD
CY2019 bios Interest On Management Notes Receivable
InterestOnManagementNotesReceivable
62000 USD
CY2019 bios Repayment Of Management Notes Receivable
RepaymentOfManagementNotesReceivable
1310000 USD
CY2019 bios Adjustments To Additional Paid In Capital Stockholders Redemption
AdjustmentsToAdditionalPaidInCapitalStockholdersRedemption
2000000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4170000 USD
CY2019 bios Stock Issued Value Restricted Stockand Stock Options Exercised Net Of Tax Withholdings
StockIssuedValueRestrictedStockandStockOptionsExercisedNetOfTaxWithholdings
2501000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-75920000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8039000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
906827000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2920000 USD
CY2020 bios Stock Issued Value Restricted Stockand Stock Options Exercised Net Of Tax Withholdings
StockIssuedValueRestrictedStockandStockOptionsExercisedNetOfTaxWithholdings
904000 USD
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
118934000 USD
CY2020 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
0 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-8076000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3977000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1015724000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9575000 USD
CY2021 bios Stock Issued Value Restricted Stockand Stock Options Exercised Net Of Tax Withholdings
StockIssuedValueRestrictedStockandStockOptionsExercisedNetOfTaxWithholdings
32000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
139898000 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
10721000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1175886000 USD
CY2021Q4 bios Number Of Service Locations
NumberOfServiceLocations
97 pharmacy
CY2021Q4 bios Number Of Infusion Sites
NumberOfInfusionSites
57 site
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2021Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 USD
CY2021Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
80100000 USD
CY2020Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
79000000 USD
CY2021Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
43000000 USD
CY2020Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
35200000 USD
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
20100000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
17000000 USD
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6000000 USD
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3300000 USD
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2800000 USD
CY2021 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2900000 USD
CY2020 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3300000 USD
CY2019 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
500000 USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3438640000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3032610000 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2310417000 USD
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
8900000 USD
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
6600000 USD
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.04
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
11600000 USD
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
9700000 USD
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
6400000 USD
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
10900000 USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-69000 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-30411000 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
996000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3072000 USD
CY2021 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
-30411000 USD
CY2020 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
927000 USD
CY2019 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
-3072000 USD
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
6817000 USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1707000 USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2074000 USD
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
190000 USD
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
199000 USD
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1276000 USD
CY2021 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
7007000 USD
CY2020 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
1906000 USD
CY2019 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
798000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-23404000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2833000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2274000 USD
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.049
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.295
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.005
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.462
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.299
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.134
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.001
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.067
CY2019 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.001
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.163
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.028
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2020Q4 bios Deferred Tax Assets Bad Debt Reserve
DeferredTaxAssetsBadDebtReserve
6907000 USD
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.007
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.003
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.082
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.022
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.007
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.201
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.540
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.029
CY2021Q4 bios Deferred Tax Assets Bad Debt Reserve
DeferredTaxAssetsBadDebtReserve
6373000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
5889000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
4058000 USD
CY2021Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
35114000 USD
CY2020Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
39094000 USD
CY2021Q4 bios Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
23266000 USD
CY2020Q4 bios Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
22644000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
97880000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
155922000 USD
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
6381000 USD
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
8501000 USD
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
174903000 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
237126000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13151000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
112085000 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
161752000 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
125041000 USD
CY2021Q4 bios Deferred Tax Liabilities Accelerated Depreciation
DeferredTaxLiabilitiesAcceleratedDepreciation
10602000 USD
CY2020Q4 bios Deferred Tax Liabilities Accelerated Depreciation
DeferredTaxLiabilitiesAcceleratedDepreciation
12593000 USD
CY2021Q4 bios Deferred Tax Liabilities Operating Lease Right Of Use Asset
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset
18437000 USD
CY2020Q4 bios Deferred Tax Liabilities Operating Lease Right Of Use Asset
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset
17186000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
61629000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
67127000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
36702000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
28976000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
7349000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
2498000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
134719000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
128380000 USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
27033000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3339000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1373000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
109531000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
109531000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
112085000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
112085000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13151000 USD
CY2021 bios Income Tax Expense Benefit Cares Act
IncomeTaxExpenseBenefitCARESAct
0 USD
CY2020 bios Income Tax Expense Benefit Cares Act
IncomeTaxExpenseBenefitCARESAct
0 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
139898000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-8076000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-75920000 USD
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179855000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180971000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
156280000 shares
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
CY2021 us-gaap Net Income Loss
NetIncomeLoss
139898000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-8076000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-75920000 USD
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179855000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180971000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
156280000 shares
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1350000 shares
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2019 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181205000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180971000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156280000 shares
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
29800000 USD
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
30800000 USD
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y7M6D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0510
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
23558000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
20508000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
14930000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
12218000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
9315000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
28052000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
108581000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
15000000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
93581000 USD
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
20700000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
230357000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
205639000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
118822000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
84490000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111535000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
121149000 USD
CY2021 us-gaap Depreciation
Depreciation
35611000 USD
CY2020 us-gaap Depreciation
Depreciation
42766000 USD
CY2019 us-gaap Depreciation
Depreciation
31808000 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2018Q4 us-gaap Goodwill
Goodwill
632469000 USD
CY2019 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
793073000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
1425542000 USD
CY2020 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
3068000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
1428610000 USD
CY2021 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
48954000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
1477564000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
530955000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
483059000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
164935000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
132007000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
366020000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
351052000 USD
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32900000 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35100000 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
26100000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
31628000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
31628000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
31628000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
31628000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
31628000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
207880000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
366020000 USD
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1100000000 USD
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
9605000 USD
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
24495000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
1065900000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6000000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1059900000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1161531000 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
13355000 USD
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
23823000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
1124353000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
9250000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1115103000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
6000000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
6000000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6000000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
6000000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
6000000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
1070000000 USD
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1100000000 USD
CY2021Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1065900000 USD
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
601000 USD
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
11342000 USD
CY2021 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
10571000 USD
CY2020 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-3977000 USD
CY2019 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-8298000 USD
CY2021 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-11539000 USD
CY2020 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-16579000 USD
CY2019 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-332000 USD
CY2021Q4 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
2800000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
9101734 shares
CY2021Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1170141 shares
CY2021Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
150890 shares
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
400000 USD
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
290117 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
383722 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
383722 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 bios Related Party Transaction Number Of Agreements
RelatedPartyTransactionNumberOfAgreements
2 agreement
CY2021 dei Auditor Firm
AuditorFirmId
185

Files In Submission

Name View Source Status
0001014739-22-000009-index-headers.html Edgar Link pending
0001014739-22-000009-index.html Edgar Link pending
0001014739-22-000009.txt Edgar Link pending
0001014739-22-000009-xbrl.zip Edgar Link pending
bios-20211231.htm Edgar Link pending
bios-20211231.xsd Edgar Link pending
bios-20211231_cal.xml Edgar Link unprocessable
bios-20211231_def.xml Edgar Link unprocessable
bios-20211231_g1.jpg Edgar Link pending
bios-20211231_g2.jpg Edgar Link pending
bios-20211231_htm.xml Edgar Link completed
bios-20211231_lab.xml Edgar Link unprocessable
bios-20211231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
opch-ex211x20211231x10k.htm Edgar Link pending
opch-ex231x20211231x10k.htm Edgar Link pending
opch-ex311x20211231x10k.htm Edgar Link pending
opch-ex312x20211231x10k.htm Edgar Link pending
opch-ex321x20211231x10k.htm Edgar Link pending
opch-ex322x20211231x10k.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending